Both in Biotechnology
Kyverna Therapeutics vs X4 Pharmaceuticals
Over the past year KYTX returned −24.9% and XFOR returned −21.6%; their daily moves had a correlation of 0.26.
KYTX −24.9% XFOR −21.6%Growth of $1, one year, split-adjusted
| Metric | KYTX | XFOR |
|---|---|---|
| Price | $5.17 | $3.21 |
| Market cap | $319.7M | $317.8M |
| Today | +0.19% | +1.10% |
| 1 month | −16.1% | +15.7% |
| 6 months | −45.4% | −26.8% |
| Year to date | −45.0% | −19.9% |
| 1 year | −24.9% | −21.6% |
| Revenue growth (YoY) | — | +346.3% |
| Gross margin | — | 81.6% |
| Net margin | — | −183.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 20.1× |
| Net cash | $174.4M | $131.2M |
| Dividend yield | — | — |
| Volatility (60d) | 59.8% | 60.7% |
| Short % of float | 26.6% | 9.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).